Print this Page
E-mail This Page
A Century of Excellence
Discover the history of one of the nation's first cancer hospitals.
Read more »
As Chief Scientific Officer, Jeff Boyd, PhD, coordinates and charts the future course of research at Fox Chase.
Boyd is an international expert in translational research and has particular expertise in the genetics of breast, ovarian and endometrial cancer. He has helped define the role of tumor suppressors and oncogenes in these malignancies, most notably the p53, BRCA1 and BRCA2 tumor suppressor genes and their role in the development of breast and ovarian cancer.
He also holds the Robert C. Young MD Chair in Cancer Research. This chair was established in 2007 through the generosity of Fox Chase Cancer Center board member Margot Keith and husband Robert Keith, as well as close friends and colleagues, to honor medical oncologist and cancer leader Robert C. Young, MD, an internationally recognized expert in lymphoma and ovarian cancer and Fox Chase’s president from 1988 to 2007. This chair recognizes and supports an outstanding leader in the field of cancer research who represents the highest standards of excellence.
Boyd's previous position was director of the Curtis and Elizabeth Anderson Cancer Institute and vice president of oncology and research at the Memorial University Medical Center in Savannah, Georgia. He also served as the professor of medicine, surgery, obstetric and gynecology at the Mercer University School of Medicine. At Mercer University, he served as the assistant dean of research. He also holds the title of Distinguished Cancer Scholar from the State of Georgia.
Prior to his roles in Savannah, Boyd served a variety of leadership roles at the Memorial Sloan Kettering Cancer Center in New York. At MSKCC, he was director of the gynecology and breast research laboratory in the department of surgery as well as the director of diagnostic molecular genetics laboratory within the department of medicine. Before serving at MSKCC, he had faculty positions at the University of Pennsylvania, the University of North Carolina and the National Institutes of Health (NIH).